UNSPSC 51385400: Nonsteroidal anti inflammatory quinolines

Nonsteroidal anti inflammatory drugs made of compounds consisting of a catabolite of tryptophan.

UNSPSC 51385400 Nonsteroidal anti-inflammatory quinolines is a Class code that shows a significant mismatch between its nominal pharmaceutical scope and the work actually being solicited under it in recent state and local opportunities. The single recent posting tagged to this code — Seminole County, Florida's IFB for naloxone and drug deactivation systems — involves emergency response and harm-reduction supplies, not anti-inflammatory medications. State and local procurement offices do not appear to be using this code for its intended pharmaceutical purpose; the naloxone procurement signals instead that the code may be incorrectly applied or that the taxonomy mapping for state and local opioid-response initiatives remains incomplete.

Seminole County, Florida is the only issuing body with a recent opportunity under this code. The July 2026 IFB sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with an initial two-year term and one-year renewal option. Response deadline was July 26, 2023 (note: the posting date of June 30, 2026 conflicts with the historical due date, suggesting a data-quality issue in the source). The procurement required electronic bid submission through the county's e-Procurement Portal, included all shipping and delivery costs in the bid, and mandated E-Verify compliance, drug-free workplace certification, and standard commercial insurance. The contract was potentially funded through FEMA, introducing additional federal compliance overlay. Given the limited and misaligned activity under this code, pursuit should be contingent on clarification whether your firm's product or service actually aligns with either the code's stated pharmaceutical scope or the harm-reduction supplies Seminole County is acquiring.